Northern Trust’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.4M Buy
2,029,885
+389,972
+24% +$6.03M ﹤0.01% 1384
2025
Q1
$24.4M Sell
1,639,913
-233,675
-12% -$3.47M ﹤0.01% 1508
2024
Q4
$24.8M Buy
1,873,588
+238,161
+15% +$3.15M ﹤0.01% 1564
2024
Q3
$23.3M Buy
1,635,427
+44,902
+3% +$639K ﹤0.01% 1527
2024
Q2
$20.6M Sell
1,590,525
-275,628
-15% -$3.57M ﹤0.01% 1546
2024
Q1
$25.9M Buy
1,866,153
+51,994
+3% +$722K ﹤0.01% 1409
2023
Q4
$25.9M Sell
1,814,159
-376,111
-17% -$5.37M ﹤0.01% 1438
2023
Q3
$33.9M Sell
2,190,270
-84,881
-4% -$1.31M 0.01% 1189
2023
Q2
$35.7M Sell
2,275,151
-486
-0% -$7.64K 0.01% 1194
2023
Q1
$37.5M Sell
2,275,637
-105,217
-4% -$1.73M 0.01% 1137
2022
Q4
$37.1M Buy
2,380,854
+188,267
+9% +$2.94M 0.01% 1129
2022
Q3
$28.4M Sell
2,192,587
-67,532
-3% -$876K 0.01% 1229
2022
Q2
$31.7M Buy
2,260,119
+40,761
+2% +$572K 0.01% 1209
2022
Q1
$31.8M Sell
2,219,358
-120,979
-5% -$1.73M 0.01% 1355
2021
Q4
$31.9M Buy
2,340,337
+77,503
+3% +$1.06M 0.01% 1442
2021
Q3
$37.1M Sell
2,262,834
-1,970,848
-47% -$32.3M 0.01% 1320
2021
Q2
$71.3M Sell
4,233,682
-325,344
-7% -$5.48M 0.01% 858
2021
Q1
$83.2M Buy
4,559,026
+179,997
+4% +$3.29M 0.02% 758
2020
Q4
$79.7M Buy
4,379,029
+132,842
+3% +$2.42M 0.02% 752
2020
Q3
$75.8M Buy
4,246,187
+429,250
+11% +$7.66M 0.02% 679
2020
Q2
$68.4M Buy
3,816,937
+403,825
+12% +$7.24M 0.02% 693
2020
Q1
$51.8M Sell
3,413,112
-332,342
-9% -$5.04M 0.01% 757
2019
Q4
$73.9M Sell
3,745,454
-170,219
-4% -$3.36M 0.02% 740
2019
Q3
$67.4M Sell
3,915,673
-147,635
-4% -$2.54M 0.02% 752
2019
Q2
$71.9M Sell
4,063,308
-155,542
-4% -$2.75M 0.02% 740
2019
Q1
$85.9M Buy
4,218,850
+803,851
+24% +$16.4M 0.02% 622
2018
Q4
$57.4M Buy
+3,414,999
New +$57.4M 0.02% 764